Delivery Order SPE2DB20D3304-SPE2DB25FW5X7
Award Date
3/25/25
Potential Completion Date
3/26/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $2,438.64, is for the delivery of Mesalamine 1,000 mg suppositories. It is a Firm Fixed Price, Delivery Order contract with an ultimate completion date of April 2, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,133.89, is for the delivery of Mesalamine 1,000 mg suppositories. It is a Firm Fixed Price Delivery Order contract with a completion date of March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,929.33, is a Firm Fixed Price Delivery Order for the supply of 4,567,795,600 units of Mesalamine 1,000 mg Suppositories. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with award ID SPE2DX15D1053|SPE2DX25F6JTQ, is for the supply of Mesalamine 1,000 mg suppositories. The contract has a ceiling value of $1,161.84 and is a firm fixed-price delivery order with a completion date of March 4, 2025. The contract was not set aside for any specific business...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine 1,000 mg suppositories. The contract has a firm fixed price of $14,257.05 and an ultimate completion date of May 20, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,044.12, is a delivery order issued by the Defense Logistics Agency (DLA) for the procurement of 4,567,342,783 units of Mesalamine 1,000 mg suppositories. The contract has an ultimate completion date of February 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,061.39 contract is for the delivery of 120-count tablets of the drug mesalamine 1.2 grams, a medication used to treat ulcerative colitis. The contract has a firm fixed price and an ultimate completion date of October 2, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds...
This federal contract award, with ID SPE2DX15D3015|SPE2DX24F0DA0, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,606.29, is for the delivery of 180 capsules of Mesalamine DR 400 mg, a medication used to treat certain types of inflammatory bowel disease. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,027.36, is for the delivery of 120 tablets of 1.2 gram Mesalamine delayed-release (DR) tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of March 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 180 tablets of 800 mg Mesalamine, a medication used to treat ulcerative colitis and Crohn's disease. The delivery order has a not-to-exceed ceiling value of $10,702.95 and a completion date of January 24, 2025. The contract is a firm fixed-price...